| Efficacy of Capecitabine With Adjuvant Radiotherapy in Treatment of Early Stages Breast Cancer (Retrospective Study). (NCT04815616) | Assiut University | 2023-04-01 |
| Breast Reconstruction and Neoadjuvant Radiotherapy (NCT05216900) | UMC Utrecht | 2023-04-01 |
| Effectiveness of Aquatic Exercise on Fatigue, Neuropathy and Quality of Life Among Cancer Patients (NCT05427344) | Tel Aviv University | 2023-04-01 |
| Ultrasound Radiomics for Predicting Breast Cancer and Axillary Lymph Node Metastasis (NCT05768451) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2023-04-01 |
| The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies (NCT05786014) | University of Virginia | 2023-04-01 |
| Optimizing Pulmonary Health and Quality of Life in Breast Cancer Survivors: A Randomized Controlled Trial Combining Incentive Spirometry and Aerobic Exercise (NCT06537336) | Hermina Hospitals | 2023-04-01 |
| Measuring Oncological Value of Exercise and Statin (NCT05796973) | Tampere University Hospital | 2023-03-31 |
| Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer Previously Treated with Conservative Surgery and Whole Breast Irradiation (NCT05772390) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2023-03-31 |
| Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer (NCT05780567) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-03-30 |
| Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients (NCT05074290) | University of Florida | 2023-03-30 |
| A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors (NCT05886075) | Shanghai Yunying Medical Technology | 2023-03-30 |
| First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors (NCT05759949) | Relay Therapeutics, Inc. | 2023-03-29 |
| Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer (NCT05735080) | Incyclix Bio | 2023-03-28 |
| FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer (NCT05755048) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2023-03-28 |
| Quality of Life After Conservative Oncoplastic Surgery in Breast Cancer Patients (IRONY: lIfe afteR ONcoplastic surgerY) (NCT05842148) | Campus Bio-Medico University | 2023-03-25 |
| Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts (NCT05625659) | American College of Radiology | 2023-03-24 |
| IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors (NCT05780307) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2023-03-23 |
| Impact of Cognitive Behavioural Therapy for Insomnia on Endocrine Therapy Adherence (NCT05887297) | University of Strathclyde | 2023-03-23 |
| Cardiac Rehabilitation for Breast Cancer Survivors (NCT06251401) | Women's College Hospital | 2023-03-21 |
| 99mTc-ABH2 SPECT/CT in Breast Cancer (NCT06194565) | Peking Union Medical College Hospital | 2023-03-20 |
| Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy (NCT05524454) | Varian, a Siemens Healthineers Company | 2023-03-20 |
| Impact of Sleep Disturbance on Cognition and Quality of Life in Breast Cancer (NCT05414357) | Centre Francois Baclesse | 2023-03-20 |
| TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients (NCT05535192) | Dana-Farber Cancer Institute | 2023-03-20 |
| Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast Cancer (NCT05101564) | Jennifer Lee Caswell-Jin | 2023-03-20 |
| The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases. (NCT05634889) | Region Skane | 2023-03-17 |
| Assessing Functional Status Needs Via PRO Measures for Pts With Metastatic Breast Cancer (NCT05755347) | UNC Lineberger Comprehensive Cancer Center | 2023-03-17 |
| Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients (NCT05732051) | University Hospital, Akershus | 2023-03-16 |
| Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks (NCT05212454) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-03-15 |
| BC Risk Assessment Before Top Surgery (NCT06239766) | Medical College of Wisconsin | 2023-03-15 |
| Efficacy and Safety of Supervised Therapeutic Exercise in Cancer Patients With and Without Concurrent Treatment. (NCT05816187) | Universidad Complutense de Madrid | 2023-03-15 |
| Different Targeted Antibody-drug Conjugates For HER2 Ultra-low or No Expression Advanced Breast Cancer（GALAXY） (NCT05824325) | Fudan University | 2023-03-14 |
| Comparison of CE-DBT and MRI in Patients With Known Breast Lesions (NCT05754749) | UNC Lineberger Comprehensive Cancer Center | 2023-03-13 |
| Ice Plant Intensive Cream for the Prevention of Hand-Foot Syndrome in Breast Cancer: Pilot Randomized Controlled Trial (NCT05755646) | University Hospital Tuebingen | 2023-03-10 |
| CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective Registry - Breast Cancer (NCT05870813) | Institut fuer Frauengesundheit | 2023-03-10 |
| Pilot Clinical Evaluation of a Microwave Imaging System for Breast Cancer Detection (NCT05757427) | MVG Industries SAS | 2023-03-09 |
| The Effect of Health Education on Breast Cancer (NCT06022900) | Saglik Bilimleri Universitesi Gulhane Tip Fakultesi | 2023-03-09 |
| To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer. (NCT05673694) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2023-03-08 |
| LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS) (NCT05677308) | AstraZeneca | 2023-03-07 |
| Tucatinib Together With Pembrolizumab and Trastuzumab (NCT04789096) | Breast Cancer Trials, Australia and New Zealand | 2023-03-07 |
| Study on Early Auxiliary Diagnosis and Postoperative Recurrence Monitoring of Breast Cancer (NCT05858242) | Singlera Genomics Inc. | 2023-03-07 |
| Effectiveness of Personalized Surveillance and Aftercare for Breast Cancer (NCT05975437) | Comprehensive Cancer Centre The Netherlands | 2023-03-06 |
| Effect of Rocuronium on BIS Values (NCT05681611) | University of Padova | 2023-03-03 |
| A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) (NCT05708950) | Kineta Inc. | 2023-03-03 |
| IMPACT Trial: Intervention to iMProve AdherenCe Equitably (NCT05496829) | Columbia University | 2023-03-02 |
| Magseed Pro(R)/ Sentimag(R) Gen3 (NCT05142787) | Endomagnetics Ltd. | 2023-03-02 |
| A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors (NCT05860374) | Shanghai Yunying Medical Technology | 2023-03-02 |
| 4D CT Scan Versus 3D CT Scan Concerning Cardiac Dosimetry Assesment for Left Sided Breast Cancers Radiotherapy (NCT05726604) | Central Hospital Saint Quentin | 2023-03-02 |
| Molecular Signature for Breast Cancer (NCT05724407) | Assistance Publique - Hôpitaux de Paris | 2023-03-01 |
| A Phase 1b/2 Trial Evaluating Safety and Efficacy of CAPecitabine in Combination With Ni-rapaRIb in HER2-negative Advanced Breast canCEr (NCT05519670) | Institut Paoli-Calmettes | 2023-03-01 |
| Autologous Fat Grafting in Radiated Soft Tissue Reconstruction (NCT05890196) | University of Chicago | 2023-03-01 |
| Effect of Montelukast on Doxorubicin Induced Cardiotoxicity in Breast Cancer (NCT05959889) | Damanhour University | 2023-03-01 |
| Clinical, Histological and In-depth Molecular Characterization as Well as Experimental Models of Liver Metastasis From Patients With Breast Cancer in Order to Identify New Potential Treatment Avenues. (NCT05720676) | KU Leuven | 2023-03-01 |
| Disitamab Vedotin(RC48) Combined With Penpulimab(AK105) for Neoadjuvant Treatment of HER2-low Breast Cancer (NCT05726175) | West China Hospital | 2023-03-01 |
| Vapocoolant Analgesia for Breast Lymphoscintigraphy (NCT05744557) | M.D. Anderson Cancer Center | 2023-03-01 |
| TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B) (NCT05573555) | Pfizer | 2023-03-01 |
| Diabetes Care for Breast Cancer Patients (NCT05565534) | Weill Medical College of Cornell University | 2023-02-28 |
| LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology (NCT05184790) | University of Sydney | 2023-02-28 |
| Breast Cancer Survivor Educational Intervention (NCT05700396) | Massachusetts General Hospital | 2023-02-28 |
| VS-6766+Abema+Fulv in Met HR+/HER- BC (NCT05608252) | Adrienne G. Waks | 2023-02-23 |
| TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A) (NCT05548127) | Pfizer | 2023-02-23 |
| Oxygen Partial Pressure After Breast Cancer Surgery (NCT05737446) | Umeå University | 2023-02-23 |
| Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer (NCT04756765) | Stanford University | 2023-02-23 |
| Effect of Kinesiotaping Augmented By Resistive Exercise on Fatigue, Physical Strength, Quality of Life in Breast Cancer Survivors (NCT05726643) | Cairo University | 2023-02-20 |
| Pilot Trial to Assess 68Ga Bombesin PET/CT (NeoB) Imaging for Staging of Breast Cancer (NCT05889728) | St Vincent's Hospital, Sydney | 2023-02-20 |
| Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid Tumors (NCT05700669) | Valerio Therapeutics | 2023-02-20 |
| A Study to Learn About the Study Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Advanced Breast Cancer in China (NCT05732428) | Pfizer | 2023-02-20 |
| Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer (NCT05797454) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-02-17 |
| NIR Fluorescent Molecular Probe for the Identification of Breast Tissue (NCT05708144) | Xiang'an Hospital of Xiamen University | 2023-02-17 |
| Digital Phenotyping in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of Treatment (NCT05634395) | Institut Curie | 2023-02-17 |
| Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer After Neoadjuvant Therapy (NCT05838001) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-02-16 |
| A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery (NCT05549505) | Arvinas Inc. | 2023-02-15 |
| Computation Prediction of Drug Response Based on Omics Data (NCT05833802) | Peking University Cancer Hospital & Institute | 2023-02-15 |
| Clinical Data Collection in Breast Tomosynthesis (COBRIS) (NCT05914168) | GE Healthcare | 2023-02-15 |
| Investigation of the Efficiency of Pain Neuroscience Education in Patients With Chronic Pain After Breast Cancer Surgery (NCT06052085) | Hacettepe University | 2023-02-15 |
| Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA (NCT06307249) | Lebanese University | 2023-02-15 |
| Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture) (NCT05472532) | Hospices Civils de Lyon | 2023-02-14 |
| Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation (NCT04711109) | Alliance for Clinical Trials in Oncology | 2023-02-14 |
| Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI (NCT05381038) | National University Hospital, Singapore | 2023-02-13 |
| Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast Cancer (NCT05633979) | M.D. Anderson Cancer Center | 2023-02-09 |
| A Health Education Intervention Tailored for Malay-Muslim Women (NCT06469684) | National University of Singapore | 2023-02-08 |
| Feasibility of Carbon-Dye Marking of Axillary Lymph Nodes Before Neoadjuvant Chemotherapy in Patients With Breast Cancer (NCT05735795) | Gaziosmanpasa Research and Education Hospital | 2023-02-07 |
| A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast Cancer (NCT05628870) | Shandong Suncadia Medicine Co., Ltd. | 2023-02-07 |
| OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk (NCT05333328) | Gangnam Severance Hospital | 2023-02-06 |
| CAR T Cells in Mesothelin-Expressing Breast Cancer (NCT05623488) | University of Pennsylvania | 2023-02-06 |
| Preventive stRategy for IMMU132-relatED AEs in TNBC or Luminal Breast Cancer- PRIMED (NCT05520723) | MedSIR | 2023-02-06 |
| Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer (NCT05982093) | SOLTI Breast Cancer Research Group | 2023-02-03 |
| The Effect of Wearable Vibration Therapy on Shoulder Functionality in Individuals Receiving Adjuvant Radiotherapy After Breast Cancer Surgery (NCT05680116) | Acibadem University | 2023-02-01 |
| Evaluation of Cognitive Management for Chemobrain in Patients Treated for Breast Cancer. (NCT05690828) | Institut Bergonié | 2023-02-01 |
| Evaluation of the Interest of a Postural and Functional Analysis for the Follow-up of the Adapted Motor Activity of Patients Treated for Breast Cancer (NCT05677022) | GCS Ramsay Santé pour l'Enseignement et la Recherche | 2023-02-01 |
| Pyrotinib Combined With Dalpiciclib Combined With Letrozole in ER-positive and HER2-positive Advanced Breast Cancer (NCT07014410) | Zhejiang Cancer Hospital | 2023-02-01 |
| RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO Experience I) (NCT05963464) | European Institute of Oncology | 2023-02-01 |
| Telemonitoring Hypertension and Breast Cancer (NCT05574686) | University of Mississippi Medical Center | 2023-02-01 |
| A Study of Eribulin-Based Regimen Versus Other Chemotherpy in Triple-Negative Metastatic Breast Cancer (ERI-Based-01). (NCT05953909) | Fujian Cancer Hospital | 2023-02-01 |
| Women In Steady Exercise Research - Window of Opportunity for Exercise and Tumor Biology (NCT05428709) | Milton S. Hershey Medical Center | 2023-02-01 |
| A Combined Exercise Training Program for Women Living With Breast Cancer (NCT05704855) | University of Toronto | 2023-02-01 |
| BENEFIT OF MECHANICAL ISCHEMIC PRECONDITIONING ON TOLERANCE OF ADIPOSE TISSUE TO ISCHEMIA REPERFUSION OF TYPE DIEP (DEEP INFERIOR EPIGASTRIC PERFORATOR) FREE FLAPS. (NCT05373069) | Assistance Publique - Hôpitaux de Paris | 2023-02-01 |
| Clinical Pilot Study for Personalized Risk-based Breast Cancer Screening (NCT05731453) | Vestre Viken Hospital Trust | 2023-02-01 |
| The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 Expression (NCT05861635) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2023-02-01 |
| The Effect of Reiki on Symptom Control and Quality of Life in Breast Cancer Patients (NCT05684458) | Ankara Medipol University | 2023-02-01 |
| Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer. (NCT05749575) | Sun Yat-sen University | 2023-02-01 |